Type I Interferon Signaling Exacerbates Chlamydia muridarum Genital Infection in a Murine Model
Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice gene...
Saved in:
Published in | Infection and Immunity Vol. 76; no. 10; pp. 4642 - 4648 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.10.2008
American Society for Microbiology (ASM) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR⁻/⁻ mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR⁻/⁻ mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR⁻/⁻ mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR⁻/⁻ mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR⁻/⁻ mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR⁻/⁻ mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR⁻/⁻ mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response. |
---|---|
AbstractList | Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of
Chlamydia muridarum
genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR
−/−
mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR
−/−
mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR
−/−
mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR
−/−
mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR
−/−
mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR
−/−
mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR
−/−
mice. These data suggest that type I IFNs exacerbate
C. muridarum
genital infection through an inhibition of the chlamydial-specific CD4 T-cell response. ABSTRACT Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR −/− mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR −/− mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR −/− mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR −/− mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR −/− mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR −/− mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR −/− mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response. Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR super(-/-) mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR super(-/-) mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR super(-/-) mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR super(-/-) mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR super(-/-) mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR super(-/-) mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR super(-/-) mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response. Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue IAI About IAI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy Connect to IAI IAI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0019-9567 Online ISSN: 1098-5522 Copyright © 2014 by the American Society for Microbiology. For an alternate route to IAI .asm.org, visit: IAI Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR⁻/⁻ mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR⁻/⁻ mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR⁻/⁻ mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR⁻/⁻ mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR⁻/⁻ mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR⁻/⁻ mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR⁻/⁻ mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response. Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR-/- mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR-/- mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR-/- mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR-/- mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR-/- mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR-/- mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR-/- mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response. |
Author | Darville, Toni Andrews, Charles W. Jr Nagarajan, Uma M Goodwin, Anna M Sikes, James D Nagarajan, Shanmugam Prantner, Daniel |
AuthorAffiliation | Division of Pediatric Infectious Diseases, Arkansas Children's Hospital Research Institute, Little Rock, Arkansas 72202, 1 Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, 2 Department of Pathology, Rockdale Medical Center, Conyers, Georgia 30012 3 |
AuthorAffiliation_xml | – name: Division of Pediatric Infectious Diseases, Arkansas Children's Hospital Research Institute, Little Rock, Arkansas 72202, 1 Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, 2 Department of Pathology, Rockdale Medical Center, Conyers, Georgia 30012 3 |
Author_xml | – sequence: 1 fullname: Nagarajan, Uma M – sequence: 2 fullname: Prantner, Daniel – sequence: 3 fullname: Sikes, James D – sequence: 4 fullname: Andrews, Charles W. Jr – sequence: 5 fullname: Goodwin, Anna M – sequence: 6 fullname: Nagarajan, Shanmugam – sequence: 7 fullname: Darville, Toni |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20683334$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18663004$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0U1vEzEQBmALFdEPuHGGFRKc2OLvtS9IVVRKpFYc2p6tiXc2Mdr1BnsD5N_jNFGBU0-W5cfj8byn5CiOEQl5zeg5Y9x8ml_MzynV3NbUPCMnjFpTK8X5ETmhlNnaKt0ck9Ocv5etlNK8IMfMaC0olSfE3W3XWM2reZwwdZjGWN2GZYQ-xGV1-Rs8pgVMmKvZqodh2waohk0KLaTNUF1hDBP05XKHfgrlbogVVDcFRKxuxhb7l-R5B33GV4f1jNx_ubybfa2vv13NZxfXtVdcTTVqrWXLkOsGLJb2GhSsBQtaq5YpsAvRNVYIRbWxRntPu9Z63jTUGMmEFWfk877uerMYsPUYpwS9W6cwQNq6EYL7_ySGlVuOPx1XUpuHAh8OBdL4Y4N5ckPIHvseIo6b7LRVDRNMPAk5k1YZZZ6EzGopGruDH_fQpzHnhN1j24y6XcauZOweMnZ0x9_8-9W_-BBqAe8PALKHvksQfciPjpcZCiF27t3ercJy9SskdJAHF8qoGr17WmrJC3q7Rx2MDpapFLq_5ZQJypSkXAnxB3pXxFM |
CODEN | INFIBR |
CitedBy_id | crossref_primary_10_1111_aji_13754 crossref_primary_10_1128_mBio_00385_19 crossref_primary_10_1128_IAI_05549_11 crossref_primary_10_1093_infdis_jiz087 crossref_primary_10_3390_ijms222111398 crossref_primary_10_1016_j_imbio_2012_01_010 crossref_primary_10_1128_IAI_00491_09 crossref_primary_10_1093_femspd_ftu028 crossref_primary_10_4049_jimmunol_0901383 crossref_primary_10_1371_journal_pone_0023135 crossref_primary_10_3389_fimmu_2014_00412 crossref_primary_10_4049_jimmunol_0900295 crossref_primary_10_3389_fimmu_2022_1001255 crossref_primary_10_1093_infdis_jiab149 crossref_primary_10_1089_jir_2015_0013 crossref_primary_10_1016_j_vaccine_2021_03_043 crossref_primary_10_1128_JVI_05671_11 crossref_primary_10_1016_j_fertnstert_2012_07_1113 crossref_primary_10_1089_vim_2019_0076 crossref_primary_10_1128_IAI_00768_16 crossref_primary_10_1371_journal_ppat_1006165 crossref_primary_10_1371_journal_pone_0146186 crossref_primary_10_1111_aji_12995 crossref_primary_10_1038_icb_2012_13 crossref_primary_10_1002_JLB_MR0318_122RR crossref_primary_10_4049_jimmunol_0902065 crossref_primary_10_1371_journal_pone_0010005 crossref_primary_10_4161_viru_1_5_12787 crossref_primary_10_4049_jimmunol_1701658 crossref_primary_10_1128_iai_00153_23 crossref_primary_10_1093_femsre_fuw027 crossref_primary_10_1128_mBio_00979_20 crossref_primary_10_1128_iai_00670_21 crossref_primary_10_4049_jimmunol_1202443 crossref_primary_10_2217_fmb_10_148 crossref_primary_10_3390_cells11010074 crossref_primary_10_1016_j_atherosclerosis_2019_09_021 crossref_primary_10_1128_microbiolspec_MCHD_0012_2015 crossref_primary_10_3389_fimmu_2018_02022 crossref_primary_10_3390_microorganisms9050973 crossref_primary_10_1016_j_immuni_2019_03_025 crossref_primary_10_1016_j_smim_2019_101328 crossref_primary_10_1093_infdis_jiab031 crossref_primary_10_3390_microorganisms10071260 crossref_primary_10_1038_s41586_023_06421_w crossref_primary_10_1128_IAI_00262_19 crossref_primary_10_1038_s41590_018_0243_7 crossref_primary_10_4049_jimmunol_0903704 crossref_primary_10_1128_IAI_00140_11 crossref_primary_10_3389_fimmu_2014_00431 crossref_primary_10_1016_j_vetimm_2011_05_036 crossref_primary_10_1038_s41598_020_75129_y crossref_primary_10_1016_j_tim_2021_01_007 crossref_primary_10_4049_jimmunol_1402794 crossref_primary_10_1038_nri3133 crossref_primary_10_1007_s12026_012_8362_y crossref_primary_10_1111_j_1462_5822_2010_01478_x crossref_primary_10_1128_mBio_00018_13 crossref_primary_10_4049_jimmunol_0903273 crossref_primary_10_1371_journal_ppat_1006388 crossref_primary_10_1016_j_chom_2022_10_013 crossref_primary_10_1093_femspd_ftab012 crossref_primary_10_1371_journal_ppat_1006383 crossref_primary_10_3390_vaccines5010003 crossref_primary_10_1111_j_1574_695X_2012_00939_x crossref_primary_10_4049_jimmunol_1001548 crossref_primary_10_4049_jimmunol_1302718 crossref_primary_10_1111_imcb_1033 crossref_primary_10_1128_IAI_01176_10 crossref_primary_10_3390_microorganisms11102449 crossref_primary_10_1155_2017_9361802 crossref_primary_10_1126_science_1233321 crossref_primary_10_1016_j_chom_2009_05_014 crossref_primary_10_2217_fmb_13_80 crossref_primary_10_1016_j_micpath_2019_103950 crossref_primary_10_1111_sji_12107 |
Cites_doi | 10.1016/S0022-1759(01)00446-X 10.4049/jimmunol.169.11.6522 10.1073/pnas.091096998 10.4049/jimmunol.171.11.6187 10.1016/j.micinf.2007.08.010 10.1128/iai.63.12.4661-4668.1995 10.1172/JCI119136 10.1126/science.8009221 10.1128/iai.48.3.847-849.1985 10.1128/iai.31.3.1161-1176.1981 10.1128/iai.64.10.3951-3956.1996 10.1084/jem.20040976 10.1128/IAI.70.2.844-850.2002 10.1128/iai.63.2.516-521.1995 10.1128/iai.63.9.3302-3308.1995 10.1016/j.cell.2007.10.034 10.1128/iai.39.1.362-370.1983 10.1038/nri1684 10.1097/01.olq.0000148299.14513.11 10.1128/IAI.68.12.6879-6882.2000 10.1016/S0070-2153(05)68006-4 10.1128/IAI.72.7.3951-3960.2004 10.1128/iai.65.8.3065-3073.1997 10.1073/pnas.84.16.5888 10.1089/107999001750133131 10.1073/pnas.0607325103 10.1128/iai.60.10.4427-4429.1992 10.4049/jimmunol.177.11.7974 10.4049/jimmunol.172.12.7417 10.1038/icb.1991.49 10.4049/jimmunol.175.1.450 10.4049/jimmunol.167.11.6453 10.4049/jimmunol.180.6.4040 10.1128/IAI.73.12.8226-8236.2005 10.1089/jir.2006.26.699 10.1016/0882-4010(86)90071-9 10.4049/jimmunol.176.11.6982 10.1084/jem.20040712 10.1136/sti.79.6.474 10.1128/IAI.69.6.3556-3561.2001 |
ContentType | Journal Article |
Copyright | 2008 INIST-CNRS Copyright © 2008, American Society for Microbiology |
Copyright_xml | – notice: 2008 INIST-CNRS – notice: Copyright © 2008, American Society for Microbiology |
DBID | FBQ IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7T5 C1K H94 7T7 8FD FR3 P64 7X8 5PM |
DOI | 10.1128/IAI.00629-08 |
DatabaseName | AGRIS Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Immunology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management Technology Research Database Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef AIDS and Cancer Research Abstracts Technology Research Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1098-5522 |
EndPage | 4648 |
ExternalDocumentID | 10_1128_IAI_00629_08 18663004 20683334 iai_76_10_4642 US201301540253 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI067678-01A2 – fundername: NIAID NIH HHS grantid: R01 AI054624 – fundername: NIAID NIH HHS grantid: AI054624 – fundername: NIAID NIH HHS grantid: R01 AI067678 – fundername: NIAID NIH HHS grantid: AI067678 |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 18M 29I 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 85S ABOCM ACGFO ADBBV AENEX AFMIJ AGCDD AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CS3 D0S DIK DU5 E3Z EBS EJD F5P FBQ FRP GX1 HYE HZ~ H~9 IH2 J5H KQ8 L7B MVM NEJ O9- OHT OK1 P2P RHF RHI RNS RPM RSF SJN TR2 TWZ UCJ UPT VH1 VQA W2D W8F WH7 WHG WOQ X7M XFK Y6R ZA5 ZGI ZXP ~KM 08R AAPBV AAUGY H13 IQODW AGVNZ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7T5 C1K H94 7T7 8FD FR3 P64 7X8 5PM |
ID | FETCH-LOGICAL-c525t-e6664d1e267a9e1867e31da9a665d15a9b3f79335068986cc0fd9c27708841393 |
IEDL.DBID | RPM |
ISSN | 0019-9567 |
IngestDate | Tue Sep 17 21:01:10 EDT 2024 Sat Oct 26 01:38:27 EDT 2024 Fri Oct 25 03:26:09 EDT 2024 Fri Oct 25 22:45:44 EDT 2024 Thu Sep 12 18:19:00 EDT 2024 Sat Sep 28 07:49:23 EDT 2024 Sun Oct 22 16:09:06 EDT 2023 Wed May 18 15:27:04 EDT 2016 Wed Dec 27 19:20:46 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Infection Animal model Microbiology Cytokine Bacteriosis Chlamydiosis Interferon Immunity |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c525t-e6664d1e267a9e1867e31da9a665d15a9b3f79335068986cc0fd9c27708841393 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Corresponding author. Mailing address: Division of Pediatric Infectious Diseases, Arkansas Children's Hospital Research Institute, 1120 Marshall Street, Room 2052, Little Rock, AR 72202. Phone: (501) 364-2479. Fax: (501) 364-2403. E-mail: nagarajanuma@uams.edu Present address: Department of Pediatrics, University of Pittsburgh Medical Center, Pittsburgh, PA 15213. Editor: B. A. McCormick |
OpenAccessLink | https://doi.org/10.1128/iai.00629-08 |
PMID | 18663004 |
PQID | 19643798 |
PQPubID | 23462 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2546839 proquest_miscellaneous_69571313 fao_agris_US201301540253 pascalfrancis_primary_20683334 pubmed_primary_18663004 proquest_miscellaneous_21495858 proquest_miscellaneous_19643798 crossref_primary_10_1128_IAI_00629_08 highwire_asm_iai_76_10_4642 |
PublicationCentury | 2000 |
PublicationDate | 2008-10-01 |
PublicationDateYYYYMMDD | 2008-10-01 |
PublicationDate_xml | – month: 10 year: 2008 text: 2008-10-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Infection and Immunity |
PublicationTitleAlternate | Infect Immun |
PublicationYear | 2008 |
Publisher | American Society for Microbiology American Society for Microbiology (ASM) |
Publisher_xml | – name: American Society for Microbiology – name: American Society for Microbiology (ASM) |
References | 17032164 - J Interferon Cytokine Res. 2006 Oct;26(10):699-705 17030789 - Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15535-9 7591120 - Infect Immun. 1995 Dec;63(12):4661-8 18083102 - Cell. 2007 Dec 14;131(6):1124-36 11404376 - J Leukoc Biol. 2001 Jun;69(6):912-20 1398955 - Infect Immun. 1992 Oct;60(10):4427-9 15213139 - Infect Immun. 2004 Jul;72(7):3951-60 7642259 - Infect Immun. 1995 Sep;63(9):3302-8 11687239 - J Immunol Methods. 2001 Nov 1;257(1-2):55-69 15302901 - J Exp Med. 2004 Aug 16;200(4):437-45 2469934 - Microb Pathog. 1986 Aug;1(4):399-407 11331036 - J Interferon Cytokine Res. 2001 Mar;21(3):137-46 6185434 - Infect Immun. 1983 Jan;39(1):362-70 2956608 - Proc Natl Acad Sci U S A. 1987 Aug;84(16):5888-92 14634135 - J Immunol. 2003 Dec 1;171(11):6187-97 15614121 - Sex Transm Dis. 2005 Jan;32(1):49-56 8926054 - Infect Immun. 1996 Oct;64(10):3951-6 11349013 - Infect Immun. 2001 Jun;69(6):3556-61 15302899 - J Exp Med. 2004 Aug 16;200(4):527-33 9120292 - J Immunol. 1997 Apr 1;158(7):3344-52 9011579 - J Clin Invest. 1997 Jan 1;99(1):77-87 16299319 - Infect Immun. 2005 Dec;73(12):8226-36 17114470 - J Immunol. 2006 Dec 1;177(11):7974-9 16110316 - Nat Rev Immunol. 2005 Sep;5(9):675-87 15972679 - J Immunol. 2005 Jul 1;175(1):450-60 9234755 - Infect Immun. 1997 Aug;65(8):3065-73 16709859 - J Immunol. 2006 Jun 1;176(11):6982-90 3997251 - Infect Immun. 1985 Jun;48(3):847-9 18322213 - J Immunol. 2008 Mar 15;180(6):4040-9 18023394 - Microbes Infect. 2007 Nov-Dec;9(14-15):1561-6 11714812 - J Immunol. 2001 Dec 1;167(11):6453-61 11796619 - Infect Immun. 2002 Feb;70(2):844-50 16124999 - Curr Top Dev Biol. 2005;68:149-81 11083808 - Infect Immun. 2000 Dec;68(12):6879-82 1787004 - Immunol Cell Biol. 1991 Oct;69 ( Pt 5):337-48 12444163 - J Immunol. 2002 Dec 1;169(11):6522-9 14663124 - Sex Transm Infect. 2003 Dec;79(6):474-8 15187119 - J Immunol. 2004 Jun 15;172(12):7417-24 7228399 - Infect Immun. 1981 Mar;31(3):1161-76 7822016 - Infect Immun. 1995 Feb;63(2):516-21 8009221 - Science. 1994 Jun 24;264(5167):1918-21 11320211 - Proc Natl Acad Sci U S A. 2001 May 8;98(10):5752-7 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 (e_1_3_2_26_2) 1997; 158 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 (e_1_3_2_11_2) 2001; 69 |
References_xml | – ident: e_1_3_2_4_2 doi: 10.1016/S0022-1759(01)00446-X – ident: e_1_3_2_37_2 doi: 10.4049/jimmunol.169.11.6522 – ident: e_1_3_2_19_2 doi: 10.1073/pnas.091096998 – ident: e_1_3_2_9_2 doi: 10.4049/jimmunol.171.11.6187 – ident: e_1_3_2_14_2 doi: 10.1016/j.micinf.2007.08.010 – ident: e_1_3_2_21_2 doi: 10.1128/iai.63.12.4661-4668.1995 – ident: e_1_3_2_30_2 doi: 10.1172/JCI119136 – ident: e_1_3_2_22_2 doi: 10.1126/science.8009221 – ident: e_1_3_2_29_2 doi: 10.1128/iai.48.3.847-849.1985 – ident: e_1_3_2_5_2 doi: 10.1128/iai.31.3.1161-1176.1981 – ident: e_1_3_2_12_2 doi: 10.1128/iai.64.10.3951-3956.1996 – ident: e_1_3_2_2_2 doi: 10.1084/jem.20040976 – ident: e_1_3_2_3_2 doi: 10.1128/IAI.70.2.844-850.2002 – ident: e_1_3_2_18_2 doi: 10.1128/iai.63.2.516-521.1995 – volume: 158 start-page: 3344 year: 1997 ident: e_1_3_2_26_2 publication-title: J. Immunol. – ident: e_1_3_2_38_2 doi: 10.1128/iai.63.9.3302-3308.1995 – ident: e_1_3_2_35_2 doi: 10.1016/j.cell.2007.10.034 – ident: e_1_3_2_32_2 doi: 10.1128/iai.39.1.362-370.1983 – ident: e_1_3_2_10_2 doi: 10.1038/nri1684 – ident: e_1_3_2_36_2 doi: 10.1097/01.olq.0000148299.14513.11 – ident: e_1_3_2_6_2 doi: 10.1128/IAI.68.12.6879-6882.2000 – volume: 69 start-page: 912 year: 2001 ident: e_1_3_2_11_2 publication-title: J. Leukoc. Biol. – ident: e_1_3_2_17_2 doi: 10.1016/S0070-2153(05)68006-4 – ident: e_1_3_2_15_2 doi: 10.1128/IAI.72.7.3951-3960.2004 – ident: e_1_3_2_7_2 doi: 10.1128/iai.65.8.3065-3073.1997 – ident: e_1_3_2_16_2 doi: 10.1073/pnas.84.16.5888 – ident: e_1_3_2_42_2 doi: 10.1089/107999001750133131 – ident: e_1_3_2_24_2 doi: 10.1073/pnas.0607325103 – ident: e_1_3_2_28_2 doi: 10.1128/iai.60.10.4427-4429.1992 – ident: e_1_3_2_31_2 doi: 10.4049/jimmunol.177.11.7974 – ident: e_1_3_2_40_2 doi: 10.4049/jimmunol.172.12.7417 – ident: e_1_3_2_13_2 doi: 10.1038/icb.1991.49 – ident: e_1_3_2_23_2 doi: 10.4049/jimmunol.175.1.450 – ident: e_1_3_2_33_2 doi: 10.4049/jimmunol.167.11.6453 – ident: e_1_3_2_41_2 doi: 10.4049/jimmunol.180.6.4040 – ident: e_1_3_2_43_2 doi: 10.1128/IAI.73.12.8226-8236.2005 – ident: e_1_3_2_27_2 doi: 10.1089/jir.2006.26.699 – ident: e_1_3_2_39_2 doi: 10.1016/0882-4010(86)90071-9 – ident: e_1_3_2_34_2 doi: 10.4049/jimmunol.176.11.6982 – ident: e_1_3_2_25_2 doi: 10.1084/jem.20040712 – ident: e_1_3_2_20_2 doi: 10.1136/sti.79.6.474 – ident: e_1_3_2_8_2 doi: 10.1128/IAI.69.6.3556-3561.2001 |
SSID | ssj0014448 |
Score | 2.2998292 |
Snippet | Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type... Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... ABSTRACT Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis highwire fao |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 4642 |
SubjectTerms | Animals Bacterial Infections Biological and medical sciences Chemokine CXCL10 - biosynthesis Chemokine CXCL9 - biosynthesis Chlamydia Chlamydia Infections - immunology Chlamydia muridarum - immunology Colony Count, Microbial Female Female Urogenital Diseases - microbiology Female Urogenital Diseases - pathology Fundamental and applied biological sciences. Psychology Interferon Type I - immunology Lymph Nodes - immunology Mice Mice, Inbred C57BL Mice, Knockout Microbiology Receptor, Interferon alpha-beta - deficiency T-Lymphocytes - immunology |
Title | Type I Interferon Signaling Exacerbates Chlamydia muridarum Genital Infection in a Murine Model |
URI | http://iai.asm.org/content/76/10/4642.abstract https://www.ncbi.nlm.nih.gov/pubmed/18663004 https://search.proquest.com/docview/19643798 https://search.proquest.com/docview/21495858 https://search.proquest.com/docview/69571313 https://pubmed.ncbi.nlm.nih.gov/PMC2546839 |
Volume | 76 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB11K4G4VFA-GgqLD3BMd-PEjn2sVi1d0CJQWak3y4mdbaTGW-2HRP89YycpXQQcOMdObM_Yfs-evAF4zyurGXLp2Fhh4yyzJi6qMo2LJC-0toWUpT_vmH3hF_Ps0xW72gPW_wsTgvbLoj5xN82Jq69DbOVtU476OLHR19nEa7jjxj4awAAdtKfo3dVBlmXd8itjBP95H-1OxWh6OvVxXFTG45CnT_AgOLWzJQ0qvXwgFuxjJfUah6tq81z8CYj-Hk_5YIM6fwoHHbIkp20PnsGedYfwqM01eXcIj2fdLfpzUJ58kikJp4GVXS0duawXHpG7BTn7oUscag9ByeQa_eUOPYg021Vt9GrbkI_W-TwjWLmN4nKkdkSTmT-1t8SnVrt5AfPzs--Ti7hLtBCXjLJNbJHDZCaxlOdaWi9xZ9PEaKk5ZyZhWhZphfM4ZWMupOBlOa6MLGme4xKFm6BMX8K-Wzp7BCSXGiEFSywCT6RuUhbSaGtwzEVRMW0i-NCPtbpt9TRU4CFUKDSPCuZRYxHBERpC6QUudWp-Sf0FK6I9RGhpBMe9dZReN6rWtcq5f0uGZCqC4Y7B7r9CsfFpmmYRvOstqHAq-fsR7exyu1ZBmyyX4u8lqOeTgv2jBJcMaX-CjXzV-sSvXnbeFkG-4y33BbzQ9-4T9P8g-N35--v_rnkMT2iv45u8gf3NamvfIpjaFEMYfP4mhmEK_QSUjhzS |
link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB21RXxcEBRKQ6H1AY7pJk7sxMdq1bIL3QqpXak3y4mdbaTGW-2HRP89YycpXQQcOMdJHM-M_Z49eQPwiVdGMeTSoTa5CdPU6LCoyiQs4qxQyhRClG6_Y3LBR9P06zW73gLW_wvjk_bLoj62t82xrW98buVdUw76PLHB98nQabjjwj7YhicYr1Hak_Tu8CBN024CFiHC_6zPd6f5YHwydplcVISRr9SXcy85tbEobVdq_kgu2GVLqiUOWNVWuvgTFP09o_LREnX2Cl522JKctN_wGraM3YWnbbXJ-114NunO0d-AdPSTjInfD6zMYm7JZT1zmNzOyOkPVeJgOxBKhjfoMffoQ6RZL2qtFuuGfDHWVRrBm9s8LktqSxSZuH17Q1xxtdu3MD07vRqOwq7UQlgyylahQRaT6thQnilhnMidSWKthOKc6ZgpUSQVRnLCIp6LnJdlVGlR0izDSQqXQZHswY6dW7MPJBMKQQWLDUJPJG9CFEIro3HM86JiSgfwuR9redcqakjPRGgu0TzSm0dGeQD7aAipZjjZyekldUesiPcQoyUBHPTWkWrZyFrVMuPuKSnSqQAONwz28BaKnU-SJA3gqLegxGByJyTKmvl6Kb06WSbyv7egjlHm7B8tuGBI_GPs5LvWJ359ZedtAWQb3vLQwEl9b17BCPCS353Hv__vO4_g-ehqci7PxxffDuAF7VV94w-ws1qszUeEVqvi0AfSTwEWHzM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELVoERWXCspHQ6H1AY5pEid27GO1dOkCW1UqK_VmObGzjdR4V_sh0X_fsZOUXQQcOMdJbM-M_Z49eoPQR1YZRYFLh9pwE2aZ0WFRlWlYJHmhlCmEKN15x_iSXUyyrzf0ZqPUl0_aL4v61N41p7a-9bmV86aM-jyx6Go8cBrusLFHc11FO-gpxGzMeqLeXSBkWdYtwiIECpD3Oe-ER6OzkcvmIiKMfbU-zrzs1NbGtFOp2YZksMuYVEuYtKqtdvEnOPp7VuXGNjV8gfY7fInP2nG8RE-MPUDP2oqT9wdob9zdpb9C0lFQPML-TLAyi5nF1_XU4XI7xec_VQkT7oAoHtyC19yDH-Fmvai1Wqwb_MVYV20EXm5zuSyuLVZ47M7uDXYF1u5eo8nw_MfgIuzKLYQlJXQVGmAymU4MYbkSxgndmTTRSijGqE6oEkVaQTSnNGZccFaWcaVFSfIcFirYCkX6Bu3amTWHCOdCAbCgiQH4CQROiEJoZTTMOS8qqnSAPvVzLeetqob0bIRwCeaR3jwy5gE6BENINYUFT06uibtmBcwHOC0N0FFvHamWjaxVLXPmvpIBpQrQ8ZbBHv9CoPNpmmYBOuktKCGg3C2Jsma2XkqvUJYL_vcWxLFKTv_RggkK5D-BTr5tfeLXKDtvC1C-5S2PDZzc9_YTiAIv-915_bv_fvME7V19Hsrvo8tvR-g56YV9k_dod7VYmw-ArlbFsY-jBykZIEY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Type+I+Interferon+Signaling+Exacerbates+Chlamydia+muridarum+Genital+Infection+in+a+Murine+Model&rft.jtitle=Infection+and+immunity&rft.au=NAGARAJAN%2C+Uma+M&rft.au=PRANTNER%2C+Daniel&rft.au=SIKES%2C+James+D&rft.au=ANDREWS%2C+Charles+W&rft.date=2008-10-01&rft.pub=American+Society+for+Microbiology&rft.issn=0019-9567&rft.eissn=1098-5522&rft.volume=76&rft.issue=10&rft.spage=4642&rft.epage=4648&rft_id=info:doi/10.1128%2FIAI.00629-08&rft.externalDBID=n%2Fa&rft.externalDocID=20683334 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0019-9567&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0019-9567&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0019-9567&client=summon |